Krka Group reported a strong financial performance in Q4 2026, with revenue surpassing EUR 2 billion for the first time in its history. The company achieved a 7% year-over-year increase in total ...

Krka Group, a prominent pharmaceutical company, reported its fourth-quarter 2026 earnings, showcasing a significant milestone by surpassing €2 billion in annual revenue for the first time. The company ...

Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces: With a ...

The Court of Cassation supported the Federal Antimonopoly Service in a dispute with KRKA-RUS LLC, which tried to challenge the decision and the order of the antimonopoly authority. This is reported on ...

(IN BRIEF) Krka has been recognised as Slovenia’s leading company in the 2025 Business Excellence survey conducted by Ninamedia, ranking first among 54 companies according to both business ...

The following slide deck was published by Krka, d. d. in conjunction with their 2025 Q4 earnings call.

January 29 (SeeNews) - Slovenian pharmaceuticals producer Krka said on Thursday it targets a net profit of 405 million euro ($484 million) in 2026, up from an estimated 401.1 million euro last year.

Copyright © 2026 Yahoo. All rights reserved.